KRMD — KORU Medical Systems, Inc.
$3.70
+$0.01 (+0.27%)
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH).
Market Cap
$160.49M
Forward P/E
185.0x
52-Week Range
N/A
KRMD Price History
Revenue vs. Net Income
$41.1M
Revenue · FY2025
Annual. Net margin is shown under each year.
Free Cash Flow
-$494K
FCF · FY2025
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
-14.9%
ROCE · FY2025
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
2.5x
Assets ÷ liabilities · FY2025
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
2.3%
CapEx · FY2025
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
+0.8%
Dilution · FY2025
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
